DNA RNA and Cells

15 Jan 2009 Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
14 Jan 2009 USA FDA Allows BioCancell to Commence Phase I/IIa Ovarian and Pancreatic Clinical Trials
13 Jan 2009 Pluristem Therapeutics Files an IND Application with the FDA to Initiate a Phase I Clinical Trial Utilizing PLX-PAD for Critical Limb Ischemia
13 Jan 2009 International Stem Cell Begins Pre-Clinical Testing of Its Parthenogenetic Stem Cells for Treatment of Retinal Disease
12 Jan 2009 Genzyme and Isis Begin New Clinical Trials of Mipomersen
09 Jan 2009 Alnylam and Cubist Form Strategic Collaboration to Develop and Commercialize RNAi Therapeutics Targeting Respiratory Syncytial Virus (RSV) Infection
08 Jan 2009 Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
08 Jan 2009 Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
08 Jan 2009 TOPIGEN Pharmaceuticals Reports Phase 2 Results of TPI ASM8 in Asthma Patients
07 Jan 2009 BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
07 Jan 2009 Cerepro(R) Application for Marketing Authorisation Accepted by EMEA
07 Jan 2009 Liquidia Technologies Announces Collaboration with Abbott to Develop siRNA Therapeutics
24 Dec 2008 AVI BioPharma Announces FDA Clearance of IND Applications for Clinical Trials of RNA Therapeutic Agents for Treatment of Ebola and Marburg Viruses
23 Dec 2008 Alnylam Advances RNAi Therapeutics Pipeline and Files Company's First Systemic Delivery IND
23 Dec 2008 GlaxoSmithKline and Archemix form strategic alliance to develop aptamers to treat inflammatory diseases
23 Dec 2008 Medistem Files IND for Endometrial Regenerative Cells in Treatment of Critical Limb Ischemia
22 Dec 2008 Intercytex Group plc – Acquisition of stem cell company Axordia Limited
19 Dec 2008 Novocell Announces Non-Exclusive Drug Discovery Collaboration with Pfizer Research to utilize Novocell’s stem cell-derived pancreatic progenitor cells
19 Dec 2008 Alnylam Publishes Pre-Clinical Research on Direct CNS Delivery of RNAi Therapeutics
18 Dec 2008 StemCells, Inc. Receives FDA Approval to Initiate Clinical Trial of HuCNS-SC(R) Cells in a Myelin Disease
18 Dec 2008 Neuralstem Files FDA Application for First ALS Stem Cell Trial
11 Dec 2008 Preclinical Studies Suggest That Living Cell Technologies NeurotrophinCell is Effective in Parkinsons Disease
11 Dec 2008 Athersys Receives IND Authorization for Multistem in Treatment of Ischemic Stroke
10 Dec 2008 Alnylam Forms Collaboration with University of California, San Francisco (UCSF) to Investigate Therapeutic Silencing of Key Gene Implicated in Uveal Melanoma
08 Dec 2008 Antisoma announces positive interim data from AS1411 phase II trial in acute myeloid leukaemia

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top